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Colon Cancer is notorious for its high mortality rates in the US. 
Sepsis, bacterial infection, is prominent among the colorectal cancer 
population. One factor commonly considered for the rise of sepsis is 
the harsh side effects of chemotherapy drugs. However, many 
undermine the effects of chemotherapy on the diversity of the gut 
microbiome, which are microbial communities within a system. This 
past year I have completed phase one of my project where I have 
developed the relationship between the 4 chemotherapeutics effect 
on the microbiome. The next phase of my experiments is to integrate 
probiotics, beneficial bacteria, to potentially remediate the effects 
caused by chemo and lower chances of contracting sepsis. This will 
be done using DNA extraction, 16sRNA amplification, and Illumina 
sequencing to compare our communities pre and post treatment. Its 
predicted that adding probiotics can mitigate changes in post 
treatment groups and potentially restore diversity. Overall implication 
is that gut microbiota are critical to the development of personalized 
cancer treatment and predicting chances of contracting sepsis among 
patients; understanding the drug-host relationship can help make 
better predictions for potential infections during treatment.
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Conclusion
• Analyze data from 16s Sequencing and send the 
samples to Sanger sequencing 
• Integrate common probiotic and understand the 
mechanism with and without the presence of 
drugs 
• Use synergistic treatments to see effect on the 
microbiome
• Extend the research to other microbiomes other 
than the gut à Skin, gut brain axis
Future Experimentation 
Introduction
Methodology
Results
When comparing to pre-treatment microbiome, we expect that 
administering dose dependent treatment of Cisplatin and Capecitabine to 
microbial communities over time will alter the microbiome, reducing the 
abundance of some taxa, while increasing the abundance of others 
(likely by simply allowing them to proliferate).
We also expect that adding probiotics (Lactobacillus; longum, and 
rhamnosus ) to post treatment microbial communities can help mitigate 
changes to the community and possibly diminish the effects of 
chemotherapy. 
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• Based on initial trials of testing viability of colonies, 
there was no significant difference in bacterial growth 
in terms of time dependence
• For all drug treatments, the 48 hour samples gave the 
highest reading for DNA compared to the 24 and 72 
hour. 
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